NCCM
BIIB icon

Nine Chapters Capital Management’s Biogen BIIB Stock Holding History

Nine Chapters Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,100
Closed -$987K – 790
2013
Q3 		$987K Buy
4,100
+500
+14% +$112K 0.12% 256
2013
Q2 		$775K Buy
+3,600
New +$769K 0.13% 233

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nine Chapters Capital Management's BIIB Position: Q4 2013 in Review

Nine Chapters Capital Management sold out of Biogen (BIIB) in Q4 2013, closing a stake of 4,100 shares — an estimated $987K sold.

Nine Chapters Capital Management first reported a position in BIIB in Q2 2013 and held it in 2 quarters. The position peaked at $987K in Q3 2013. 738 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

  • Nine Chapters Capital Management reported no remaining Biogen position as of Q4 2013 after selling out during the quarter.
  • Nine Chapters Capital Management sold 4,100 Biogen shares in Q4 2013, an estimated $987K.
  • Nine Chapters Capital Management first reported a position in Biogen in Q2 2013 and held it in 2 quarters.
  • Nine Chapters Capital Management's Biogen position peaked at $987K in Q3 2013.
  • 738 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on Nine Chapters Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.